Furthermore, the anticancer impact of CMC-AgNPs is due to the induction of apoptosis and necrosis in hepatic cancer cells by increasing caspase-8 and -9 activity and decreasing VEGFR-2. This evidence concerns the gene KDR and liver cancer.